Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
michael.pavlides@cardiov.ox.ac.uk

Research groups

Pavlides Group: Quantitative MR and liver disease

Michael Pavlides

Head of liver imaging at OCMR

Principal Investigator
Honorary consultant at Oxford University Hospitals NHS Trust

Recent publications

Detection and alterations of acetylcarnitine (AC) in human liver by 1 H MRS at 3T after supplementation with l-carnitine.
Journal article

Savic D. et al, (2022), Magn Reson Med
Comparison of liver iron concentration calculated from R2* at 1.5 T and 3 T
Journal article

Pickles E. et al, (2022), Abdominal Radiology
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
Journal article

PHOSP-COVID Collaborative Group None., (2022), Lancet Respir Med, 10, 761 - 775
Association between patient-reported outcome measures and surrogate markers of liver fibrosis in large-duct primary sclerosing cholangitis
Conference paper

Selvaraj E. et al, (2022), JOURNAL OF HEPATOLOGY, 77, S320 - S320
Association between patient-reported outcome measures and severity of cholangiopathy in large-duct primary sclerosing cholangitis
Conference paper

Selvaraj E. et al, (2022), JOURNAL OF HEPATOLOGY, 77, S320 - S321

More publications